Controlled Substances Act - Updates.

HB 330 updates North Carolina's Controlled Substances Act by adding specific synthetic drugs and chemical structures to Schedule I, making them illegal without exception. It directly affects law enforcement, healthcare providers, and individuals using these substances, as it automatically controls new variants of fentanyl derivatives (like 4-fluorofentanyl), nitazenes, synthetic cannabinoids (including indole carboxamides), and other novel psychoactive substances based on their chemical structure - not just named compounds. Key mechanisms include defining "structurally derived" compounds (e.g., fentanyl modifications) and listing specific examples to close loopholes where manufacturers alter molecules slightly to evade existing laws. This policy change aims to address emerging drug threats by expanding the legal definition of controlled substances.